A Mouse Model for Latent Tuberculosis

References

• Bloom BR, Fine PEM. The BCG experience: Implication for future vaccines against TB. In: Bloom BR, editor. Tuberculosis: pathogenesis, protection and control. Washington DC: ASM Press 1994: 531–57.
   Google Scholar
• Colditz GA, Brewer TF, Berkey CS, Wilson ME, Burdick E, Fineberg HV, Mosteller F. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 1994; 271: 698–702.
   Google Scholar
• Sutherland I, Lindgren I. The protective effect of BCG vaccination as indicated by autopsy studies. Tubercle 1979; 60: 225–31.
   PubMedGoogle Scholar
• Rouillon A, Perdrizet S, Parrot R. Transmission of tubercle bacilli: The effects of chemotherapy. Tubercle 1976; 57: 275–99.
   Google Scholar
• Brudney K, Dobkin J. Resurgent tuberculosis in New York City: Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991; 144: 745–9.
   PubMed Web of Science ®Google Scholar
• Weissler JC. Southwestern internal medicine conference: Tuberculosis-immunopathogenesis and therapy. Am J Med Sci 1993; 305: 52–65.
   PubMed Web of Science ®Google Scholar
• Groth-Petersen E, Knudsen J, Wilbek E. Epidemiological basis of tuberculosis eradication in an advanced country. Bull WHO 1959; 21: 5–49.
   Google Scholar
• Stead WW. Pathogenesis of a first episode of chronic pulmonary TB in man: Recrudescence of residuals of the primary infection or exogenous reinfection. Am Rev Respir Dis 1967; 95: 729–45.
   PubMed Web of Science ®Google Scholar
• Stead WW, To T. The significance of the tuberculin skin test in elderly persons. Ann Intern Med 1987; 107: 837–42.
   PubMed Web of Science ®Google Scholar
• Tabet SR, Goldbaum GM, Hooton TM, Eisenach KD, Cave MD, Nolan CM. Restriction fragment length polymorphism analysis detecting a community-based tuberculosis outbreak among persons infected with human immunodeficiency virus. J Infect Dis 1994; 169: 189–92.
   PubMed Web of Science ®Google Scholar
• Daley CL, Small PM, Schecter GF, Schoolnik GK, McAdam RA, Jacobs WR, Hopewell PC. An outbreak of tuberculosis with accelerated progression among persons infected with human immunodeficiency virus: An analysis using restriction-fragment-length polymorphisms. N Engl J Med 1992; 326: 231–5.
   Google Scholar
• Coronado VG, Beck-Sague CM, Hutton MD, Davis BJ, Nicholas P, Villareal C, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis among persons with human immunodeficiency virus infection in an urban hospital: epidemiologic and restriction fragment length polymorphism analysis. J Infect Dis 1993; 168: 1052–5.
   PubMed Web of Science ®Google Scholar
• Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, Drucker E, Bloom BR. Transmission of tuberculosis in New York City: An analysis by DNA fingerprinting and conventional epidemiologic methods. New Engl J Med 1994; 330: 1710–6.
   PubMed Web of Science ®Google Scholar
• Small PM, Hopewell PC, Singh SP, Paz A, Parsonnet J, Ruston DC, et al. The epidemiology of tuberculosis in San Francisco: A population-based study using conventional and molecular methods. N Engl J Med 1994; 330: 1703–9.
   PubMed Web of Science ®Google Scholar
• Frieden TR, Woodley CL, Crawford JT, Lew D, Dooley SM. The molecular epidemiology of tuberculosis in New York City: the importance of nosocomial transmission and laboratory error. Tuberc Lung Dis 1996; 77: 407–13.
   Google Scholar
• Genewein A, Telenti A, Bernasconi C, Mordasini C, Weiss S, Maurer A-M, et al. Molecular approach to identifying route of transmission of tuberculosis in the community. Lancet 1993; 342: 841–4.
   Google Scholar
• Styblo K. Epidemiology of tuberculosis: In selected papers. Roy Netherl Tuberc Assoc 1991; 24: 1–136.
   Google Scholar
• Snider DE. Tuberculosis: the world situation. History of disease and efforts to combat it. In: Porter JDH, McAdam KPWJ, editors. Tuberculosis back to the future. London: John Wiley & Sons Ltd, 1994: 13–31.
   Google Scholar
• Smith PG, Moss AR. Epidemilogy of tuberculosis. In: B. R. Bloom, editor. Tuberculosis: pathogenesis, protection and control. Washington DC: ASM Press, 1994: 47–59.
   Google Scholar
• Medlar FM. Primary and reinfection tuberculosis as the cause of death in adults. An analysis of 100 consecutive necropsies. Am Rev Tuberc 1947; 55: 517–28.
   Google Scholar
• Hopewell PC. Overview of clinical Tuberculosis. In: Bloom BR, editor. Tuberculosis: pathogenesis, protection and control. Washington, DC: ASM Press, 1995: 25–46.
   Google Scholar
• Davies PDO. Adult tuberculosis: In: Hart CA, Beeching NJ, Duerden BI, editors. Tuberculosis into the next century. J Med Microbiol, 1996: 44: 1–34.
   Google Scholar
• Murray CJL, Styblo K, Rouillon A. Tuberculosis. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis 1990; 65: 6–24.
   PubMedGoogle Scholar
• Styblo K. Epidemiology of tuberculosis. VEB Gustav Fischer Verlag Jena: The Hague 1984.
   Google Scholar
• Hart PD, Rees RJW. Enhancing effect of cortisone on tuberculosis in the mouse. Lancet 1950; 2: 391–5.
   PubMed Web of Science ®Google Scholar
• Hart PD, Rees RJW. Effect of Macrocyclon in acute and chronic pulmonary tuberculous infection in mice as shown by viable and total bacterial counts. Br J Exp Pathol 1960; 41: 414–21.
   PubMedGoogle Scholar
• Rees RJW, Hart PD. Analysis of the host-parasite equilibrium in chronic murine tuberculosis by total and viable bacillary counts. Br J Exp Pathol 1961; 42: 83–8.
   PubMed Web of Science ®Google Scholar
• McCune RM, Feldmann FM, Lambert HP, McDermott W. Microbial resistance. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J Exp Med 1966; 123: 445–68.
   Google Scholar
• McCune RM, Feldmann FM, McDermott W. Microbial resistance. II. Characteristics of the sterile state of tubercle bacilli. J Exp Med 1966; 123: 469–86.
   Google Scholar
• Brown DH, Miles BA, Zwilling BS. Growth of Mycobacterium tuberculosis in BCG-resistant and -susceptible mice: Establishment of latency and reactivation. Infect Immunol 1995; 63: 2243–7.
   Google Scholar
• Orme IM. A mouse model of the recrudescence of latent tuberculosis in the elderly. Am Rev Respir Dis 1988; 137: 716–8.
   PubMed Web of Science ®Google Scholar
• Data sheet from Bomholtga˚rd Breeding and Research Centre Ltd., Denmark 1995.
   Google Scholar
• Mshana RN, Humber DP, Harboe M, Belehu A. Demonstration of Mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique. Clin Immunol Immunopathol 1983; 29: 359–68.
   PubMedGoogle Scholar
• Wiley EL, Mulhollan TJ, Beck B, Tyndall JA, Freeman RG. Polyclonal antibodies raised against Bacillus Calmette-Guerin, Mycobacterium duvalii, and Mycobacterium paratuberculosis used to detect mycobacteria in tissue with the use of immunohistochemical techniques. Am J Clin Pathol 1990; 94: 307–12.
   Google Scholar
• Opie EL, Aronson JD. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch Pathol Lab Med 1927; 4: 1–21.
   Google Scholar
• Feldman WH, Baggenstoss AH. The residual infectivity of the primary complex of tuberculosis. Am J Pathol 1938; 14: 473–93.
   PubMedGoogle Scholar
• Griffith AS. Types of tubercle bacilli in human tuberculosis. J Patho Bact 1929; 32: 813–40.
   Google Scholar
• Schwabacher H, Wilson GS. The inoculation of minimal doses of tubercle bacilli into guinea-pigs, rabbits and mice. Tubercle 1937; 18: 442–54.
   Google Scholar
• Wayne LG. Dynamics of submerged growth of Mycobacterium tuberculosis under aerobic and microaerophilic conditions. Am Rev Respir Dis 1976; 114: 807–11.
   PubMed Web of Science ®Google Scholar
• Wayne LG. Synchronized replication of Mycobacterium tuberculosis. Infect Immunol 1977; 17: 528–30.
   PubMed Web of Science ®Google Scholar
• Wayne LG, Lin K-Y. Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions. Infect Immunol 1982; 37: 1042–9.
   Google Scholar
• Wayne LG. Dormancy of Mycobacterium tuberculosis and latency of disease. Eur J Clin Microbiol Infect Dis 1994; 13: 908–14.
   PubMed Web of Science ®Google Scholar
• Wayne LG, Hayes LG. An in vitro model for the sequential study of shiftdown of Mycobacterium tuberculosis through 2 stages of nonreplicating persistence. Infect Immunol 1996; 64: 2062–9.
   PubMed Web of Science ®Google Scholar
• DeMaio J, Zhang Y, Ko C, Young DB, Bishai WR. A stationary-phase stress-response sigma factor from Mycobacterium tuberculosis. Proc Natl Acad Sci USA 1996; 93: 2790–4.
   Google Scholar
• Lefford MJ. Diseases in the mice and rats. In: Kubica GP, Wayne LG, editors. The Mycobacteria—a source book. New York: Marcel Dekker, 1984: 947–74.
   Google Scholar
• Nyka W, Faherty JF, Malone L C, Kiser JS. A histological study of the pathogenesis of tuberculosis in mice experimentally infected with bacilli of human type. Exp Med Surg 1954; 12: 367–429.
   PubMedGoogle Scholar
• Yamamura Y, Walter A, Bloch H. Bacterial populations in experimental murine tuberculosis. I. Studies in normal mice. J Infect Dis 1960; 106: 211–22.
   Google Scholar
• Mayer E, Jackson ER, Whiteside ES, Alverson C. Experimental embolic pulmonary tuberculosis in mice. Am Rev Tuberc 1954; 69: 419–42.
   PubMedGoogle Scholar
• Raleigh GW, Youmans GP. The use of mice in experimental chemotherapy of Tuberculosis: II. Pathology and pathogenesis. J Infect Dis 1948; 82: 205–20.
   Google Scholar
• Vandiviere HM, Loring WE, Melvin I, Willis S. The treated pulmonary lesion and its tubercle bacillus. II. The death and resurrection. Am J Med Sci 1956; 232: 30–7.
   PubMedGoogle Scholar
• Dagnæs-Hansen F. Laboratory animal genetics and genetic monitoring. In: Svendsen P, Hau J, editors. Handbook of laboratory animal science. Selection and handling of animals in biomedical research, vol. 1. Boca Raton, FL: CRC Press, Inc., 1994.
   Google Scholar
• Buschman E, Apt AS, Nickonenko BV, Moroz AM, Averbakh MH, Skamene E. Genetic aspects of innate resistance and acquired immunity to mycobacteria in inbred mice. Springer Semin Immunopathol 1988; 10: 319–36.
   PubMed Web of Science ®Google Scholar
• Orme IM, Collins FM. Mouse model of tuberculosis. In: Bloom BR, editor. Tuberculosis: pathogenesis, protection, and control. Washington, DC; ASM Press, 1995: 113–34.
   Google Scholar
• Costello R, Izumi T. Measurement of resistance to experimental tuberculosis in albino mice. J Exp Med 1971; 133: 362–75.
   PubMed Web of Science ®Google Scholar
• Abbas AK, Lichtman AH, Pober JS. Regulation of immune responses. In Cellular and molecular immunology. 2nd ed. Philadelphia: W.B. Saunders Co., 206–7 1994.
   Google Scholar
• Conradt P, Kaufmann SHE. Impact of antigen-presenting cells on cytokine profiles of human Th clones established after stimulation with Mycobacterium tuberculosis antigens. Infect Immunol 1995; 63: 2079–81.
   PubMed Web of Science ®Google Scholar
• Youmans GP, Youmans AS. The relation between the size of the infecting dose of tubercle bacilli and the survival time of mice. Am Rev Tuberc 1951; 64: 534–40.
   PubMedGoogle Scholar